title: Japanese guidelines for allergic rhinitis 2017.
abstract: Like asthma and atopic dermatitis, allergic rhinitis is an allergic disease, but of the three, it is the only type I allergic disease. Allergic rhinitis includes pollinosis, which is intractable and reduces quality of life (QOL) when it becomes severe. A guideline is needed to understand allergic rhinitis and to use this knowledge to develop a treatment plan. In Japan, the first guideline was prepared after a symposium held by the Japanese Society of Allergology in 1993. The current 8th edition was published in 2016, and is widely used today. To incorporate evidence based medicine (EBM) introduced from abroad, the most recent collection of evidence/literature was supplemented to the Practical Guideline for the Management of Allergic Rhinitis in Japan 2016. The revised guideline includes assessment of diagnosis/treatment and prescriptions for children and pregnant women, for broad clinical applications. An evidence-based step-by-step strategy for treatment is also described. In addition, the QOL concept and cost benefit analyses are also addressed. Along with Allergic Rhinitis and its Impact of Asthma (ARIA), this guideline is widely used for various clinical purposes, such as measures for patients with sinusitis, childhood allergic rhinitis, oral allergy syndrome, and anaphylaxis and for pregnant women. A Q&A section regarding allergic rhinitis in Japan was added to the end of this guideline.
authors.affiliation: Department of Otorhinolaryngology, Nippon Medical School, Tokyo, Japan. Electronic address: ent-kimi@nms.ac.jp.
authors.forename: Kimihiro
authors.initials: K
authors.lastname: Okubo
authors.affiliation: Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Kurono
authors.affiliation: Jichi Medical University, Tochigi, Japan.
authors.forename: Keiichi
authors.initials: K
authors.lastname: Ichimura
authors.affiliation: Tottori University Faculty of Medicine, Tottori, Japan.
authors.forename: Tadao
authors.initials: T
authors.lastname: Enomoto
authors.affiliation: Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Okamoto
authors.affiliation: Department of Otorhinolaryngology, Shimane University Faculty of Medicine, Shimane, Japan.
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Kawauchi
authors.affiliation: Nasal and Paranasal Sinus Disease and Allergy Institute, Tokyo General Hospital, Tokyo, Japan.
authors.forename: Harumi
authors.initials: H
authors.lastname: Suzaki
authors.affiliation: Division of Otorhinolaryngology, Head & Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Medical Science, University of Fukui, Fukui, Japan.
authors.forename: Shigeharu
authors.initials: S
authors.lastname: Fujieda
authors.affiliation: Department of Otorhinolaryngology, Head & Neck Surgery, University of Yamanashi, Yamanashi, Japan.
authors.forename: Keisuke
authors.initials: K
authors.lastname: Masuyama
mesh_terms: D000066491:Clinical Decision-Making; D003131:Combined Modality Therapy / Q000009:adverse effects / Q000379:methods; D003937:Diagnosis, Differential; D019468:Disease Management; D006801:Humans; D007564:Japan; D010641:Phenotype; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D065631:Rhinitis, Allergic / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors; D012720:Severity of Illness Index
keywords: Allergen immunotherapy; Mechanism; Pharmacotherapy; Pollinosis; Surgery